Registry of Older Patients With Cancer

Lymphoma Clinical Trial

Official title: Carolina Senior: UNC Registry for Older Cancer Patients

Status Recruiting

Clinical Trial Summary

RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering information from older patients with cancer into a registry.

Clinical Trial Description

OBJECTIVES: Primary - To create a registry (to be called "Carolina Senior") of older patients with an appointment at North Carolina Cancer Hospital. - To have these patients complete a Geriatric Assessment (GA). Secondary - To measure the response rates of GAs of Carolina Senior patients and their satisfaction with a GA by measuring the percentage of patients contacted who consent to complete the GA; the percentage of patients able to complete the self-administered portion of the GA without assistance; the length of time necessary to complete the GA; the variance and number of missing items; the percentage of GAs that contain all 3 of the following items: Timed Up and Go Assessment, Blessed Orientation-Memory-Concentration Test, and healthcare professional-rated Karnofsky performance status; and patient satisfaction with the questionnaire by identifying items that are distressing or too difficult to comprehend. - To gather information, including patterns of patient care, that would lend support for future research in the 'Carolina Senior' population who receive a confirmed diagnosis of cancer (except for nonmelanoma skin cancer, cervical carcinoma in situ without evidence of disease, or prostatic intraepithelial neoplasia without evidence of prostate cancer). OUTLINE: Patients complete a geriatric assessment, a multi-dimensional inter-disciplinary patient evaluation that includes an evaluation of a patient's functional status (ability to live independently at home and in the community), co-morbid medical conditions, cognition, psychological status, social functioning and support, medication review, and nutritional status. Patients' medical records are also reviewed. Patients' health status at 1 year is incorporated into the registry. ;

Related Conditions & MeSH terms

• Chronic Myeloproliferative Disorders
• Cognitive/Functional Effects
• Leukemia
• Lymphoma
• Lymphoproliferative Disorder
• Lymphoproliferative Disorders
• Multiple Myeloma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Syndromes
• Myelodysplastic-Myeloproliferative Diseases
• Myelodysplastic/Myeloproliferative Neoplasms
• Myeloproliferative Disorders
• Neoplasms
• Neoplasms, Plasma Cell
• Plasmacytoma
• Preleukemia
• Syndrome
• Unspecified Adult Solid Tumor, Protocol Specific

• NCT number: NCT01137825
• Study type: Observational
• Source: UNC Lineberger Comprehensive Cancer Center
• Contact: Kirsten A Nyrop, PhD
• Phone: (919) 962-5139
• Email: knyrop@med.unc.edu
• Status: Recruiting
• Start date: September 2009
• Completion date: December 2030